Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
dailyer is a clinical follow-up platform for patients undergoing GLP-1 treatment. It aims to address the lag in information after patients leave the consultation room, such as missed doses, symptoms like nausea, and weight changes. It is not a medical device: the page clearly states that it does not diagnose conditions or modify prescriptions, and that physicians remain responsible for clinical decisions.
The product consists of three parts: a clinical dashboard, a patient App, and an integrated supplement store. The dashboard ranks patients by red, yellow, and green risk status, aggregates adherence, weight, symptoms, and injection records, and supports medication- and phase-based alert configuration as well as pre-visit PDF summaries. The patient App handles dose reminders, prescription-based titration calendars, injection-site rotation cooldowns, brief daily symptom logging, and weekly weight tracking. The store recommends supplements such as protein, electrolytes, fiber, and multivitamins based on symptoms; clinics can review the catalog and receive a share of the revenue. In terms of integrations, the clinic plan supports HCE PDF/Excel exports and store integration, while the hospital plan supports SSO, HL7/FHIR, and connections with hospital systems.
Pricing is relatively clear: Solo costs €39/month/specialist, supports up to 50 active patients, and includes the dashboard, alerts, the dailyer-branded App, and email support. Clínica costs €129/month/specialist, supports unlimited patients, and includes a white-label App, HCE and Excel exports, store integration, onboarding, and dedicated support. Hospital is priced by custom quote and offers European hosting, BAA, aggregated reporting, and an implementation team. The page also mentions the first month is free, but does not indicate a permanently free plan. For customer support, the FAQ says email replies are provided within 24 hours, and in-clinic demos are available.
The main strength is its highly focused use case: dailyer builds a closed loop around GLP-1 follow-up, connecting lightweight patient input, physician risk triage, and pre-visit summaries. For private endocrinology clinics and obesity-management programs, it can reduce the time spent reconstructing patient history during consultations. Limitations include the fact that advanced interoperability is mainly reserved for the hospital plan, while information on broader chronic-disease management, granular permissions, open APIs, audit security, and related capabilities is limited. The supplement-store revenue-sharing model also requires healthcare institutions to assess compliance and potential conflicts of interest on their own.
The page does not provide information on access from China, a Chinese interface, domestic payment methods, or compliance with local medical-data regulations, so china_access can only be rated as unknown. For deployment in China, key issues to verify would include network availability, cross-border data transfer, patient privacy, medical advertising rules, and medical device/drug compliance. Alternative options include domestic hospital follow-up systems, internet-hospital patient management platforms, chronic-disease management SaaS products, and follow-up modules from electronic medical record vendors.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on dailyer.com official site.
dailyer.com is an Spain Health provider. TG4G tracks its product information, with monthly pricing from $42.00, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach dailyer.com directly.